Alex Tarnava

What if something's going on that I don't know?

I want to demonstrate it and I want to advance the research.

So I emailed every first and every corresponding author on every study on hydrogen at the time.

I offered them free product, free placebo donations to strengthen their studies and no ownership over the data, you know, meaning that they can publish the results, whether it works or it doesn't, because I only want to sell it if it works.

I don't, I don't think anyone is trustworthy enough to have that power, you know?

Because what ends up happening?

Say I have a contract that I get to the site of it published.

And now I've spent hundreds of thousands or millions of dollars and years of my life doing something.

I could justify, well, this trial was bullshit, right?

They did it wrong.

I don't want to publish it.

And it's very easy to fool ourselves and trick ourselves in this way.

So because I have that conflict, I don't want that power to do it.

And that is this philosophy is why I have what would probably be valued in the research in the nine figure range.

If it had been through contract research organizations, but it's been primarily government grants and, you know, investigator initiated trials that they've gotten funding from their universities and

grants and the government to do this research because they own the data and usually industry won't do this but because of the compromise i made with myself when i entered i committed myself to doing it this way and i'm just lucky and fortunate that it has panned out and that the results have been good

Exactly.

So if industry and that is not just pharma, that is the supplement industry, it's worse there.

Exactly.

So when I mentioned shareholder primacy, so that was a Supreme Court of Michigan ruling in 1919.